The project aims are: 1) to define the pharmacological profile of the primate aqueous humor formation and drainage apparatus in terms of its physiological and morphological responses; 2) to define and to understand the pathophysiology of the functional and morphological toxicity of currently used antiglaucoma drugs. The influence of drugs on aqueous humor formation and drainage in the living monkey eye will be studied using invasive perfusion techniques and noninvasive fluorophotometric techiques. In some eyes, the ciliary muslce will be disconnected from the scleral spur so that drug effects on the function of the trabecular meshowrk will not be distorted by dru-induced changes in ciliary muscle tone. Other eyeswill be parasympathetically denervated via ciliary ganglionectomy to assess the role of intact cholinergic innvervation in mediating drug responses. The effects of cholinergics, adrenergics, cyclic nucleotides, hormones, peptides, prostaglandings, cytochalasins, chelators, cannabinoids, ionophores, carbonic anhydrase inhibitors, and corticosteroids will be assessed using putative agonists, antagonists, mdiators, and metabolites, and interactions among different drug classes will be sought. The morphological basis for any drug-induced functional changes will be studied electron microscopically. These studies should improve our understanding of the basic mechanisms of aqueouos humor formation and drainage in the primate eye, and thus may enhace our knowledge of the pathophysiology of human glaucoma and contribute to new pharmacological approaches to its treatment.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY002698-07
Application #
3257060
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1979-07-01
Project End
1986-08-31
Budget Start
1985-07-01
Budget End
1986-08-31
Support Year
7
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Lu, Wennan; Hu, HuiLing; Sévigny, Jean et al. (2015) Rat, mouse, and primate models of chronic glaucoma show sustained elevation of extracellular ATP and altered purinergic signaling in the posterior eye. Invest Ophthalmol Vis Sci 56:3075-83
Lee, Eun Suk; Rasmussen, Carol A; Filla, Mark S et al. (2014) Prospects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivo. Curr Eye Res 39:859-70
Aktas, Zeynep; Tian, Baohe; McDonald, Jared et al. (2014) Application of canaloplasty in glaucoma gene therapy: where are we? J Ocul Pharmacol Ther 30:277-82
Tian, Baohe; Kaufman, Paul L (2013) A Potential Application of Canaloplasty in Glaucoma Gene Therapy. Transl Vis Sci Technol 2:
Gabelt, B'ann T; Rasmussen, Carol A; Tektas, Ozan Y et al. (2012) Structure/function studies and the effects of memantine in monkeys with experimental glaucoma. Invest Ophthalmol Vis Sci 53:2368-76
Tian, Baohe; Kaufman, Paul L (2012) Comparisons of actin filament disruptors and Rho kinase inhibitors as potential antiglaucoma medications. Expert Rev Ophthalmol 7:177-187
Kiland, Julie A; Gabelt, B'ann T; Kaufman, Paul L (2011) Relationship of aqueous outflow resistance to age and total volume perfused in rhesus and cynomolgus monkeys. Invest Ophthalmol Vis Sci 52:6820-4
Elsmo, Elizabeth J; Kiland, Julie A; Kaufman, Paul L et al. (2011) Evaluation of rebound tonometry in non-human primates. Exp Eye Res 92:268-73
Gabelt, B'Ann T; Kaufman, Paul L; Rasmussen, Carol A (2011) Effect of nitric oxide compounds on monkey ciliary muscle in vitro. Exp Eye Res 93:321-7
Ly, Tina; Gupta, Neeru; Weinreb, Robert N et al. (2011) Dendrite plasticity in the lateral geniculate nucleus in primate glaucoma. Vision Res 51:243-50

Showing the most recent 10 out of 211 publications